MCPCON 2023 - Day 2 | Medical Writing, Clinical Research, Pharmacovigilance Conference

MCPCON 2023 - Day 2 | Medical Writing, Clinical Research, Pharmacovigilance Conference

4-Day Certificate Program on Pharmacovigilance and Medical WritingПодробнее

4-Day Certificate Program on Pharmacovigilance and Medical Writing

Salary in Clinical Research 🧐, Medical Writing ✍️, Pharmacovigilance, Data 📈ManagementПодробнее

Salary in Clinical Research 🧐, Medical Writing ✍️, Pharmacovigilance, Data 📈Management

FREE WEBINAR & DEMO CLASS | FUNDAMENTALS OF CLINICAL RESEARCH | CLIMED INDIAПодробнее

FREE WEBINAR & DEMO CLASS | FUNDAMENTALS OF CLINICAL RESEARCH | CLIMED INDIA

MCPCON 2023 - Day 1 | Medical Writing, Clinical Research, Pharmacovigilance ConferenceПодробнее

MCPCON 2023 - Day 1 | Medical Writing, Clinical Research, Pharmacovigilance Conference

International online Conference on Pharmacovigilance and Clinical Research Day 2 : 2nd August 2020Подробнее

International online Conference on Pharmacovigilance and Clinical Research Day 2 : 2nd August 2020

2nd webinar of series SPAN-HNC “Navigating Treatment Options: Locating the Right Path to Recovery”Подробнее

2nd webinar of series SPAN-HNC “Navigating Treatment Options: Locating the Right Path to Recovery”

International Conferences in Clinical Research and Pharmaceutical Sciences (CRPS 2023)Подробнее

International Conferences in Clinical Research and Pharmaceutical Sciences (CRPS 2023)

2nd International Conferences in Clinical Research and Pharmaceutical Sciences (CRPS 2024)Подробнее

2nd International Conferences in Clinical Research and Pharmaceutical Sciences (CRPS 2024)

Seminar session in Clinical Research and pharmacovigilanceПодробнее

Seminar session in Clinical Research and pharmacovigilance

Clinical Considerations for Metoclopramide and CYP2D6 | August 16, 2024Подробнее

Clinical Considerations for Metoclopramide and CYP2D6 | August 16, 2024

AI in Pharmacovigilance with Jan Petracek, Director Institute of PharmacovigilanceПодробнее

AI in Pharmacovigilance with Jan Petracek, Director Institute of Pharmacovigilance